Comvita Limited (CVNZF)
| Market Cap | 56.23M +132.6% |
| Revenue (ttm) | 121.22M +8.0% |
| Net Income | -53.90M |
| EPS | -0.76 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | 14.86 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 500 |
| Open | 0.4161 |
| Previous Close | 0.4303 |
| Day's Range | 0.4161 - 0.4161 |
| 52-Week Range | 0.3163 - 0.4354 |
| Beta | 0.26 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 25, 2026 |
About Comvita
Comvita Limited, together with its subsidiaries, engages in research, manufacturing, marketing, and distribution nature health products in Australia, New Zealand, Greater China, rest of Asia, North America, Europe, the Middle East, Africa, and internationally. The company offers Manuka honey, propolis, olive leaf extract, medihoney, bundles, bulk packs, and elixirs and lozenges, as well as oral care and kids health products. It also engages in the apiary ownership and forest management activities. The company sells its products online through i... [Read more]
Financial Performance
In fiscal year 2025, Comvita's revenue was 192.43 million, a decrease of -4.11% compared to the previous year's 200.68 million. Losses were -104.76 million, 30.3% more than in 2024.
Financial numbers in NZD Financial StatementsNews
Comvita Slides: Investor presentation
Comvita has posted slides in relation to its latest quarterly earnings report, which was published on April 14, 2026.
Comvita Earnings Call Transcript: H1 2026
Strong H1 performance with improved profitability, cash flow, and reduced net debt and inventory. North America drives growth, while China and ANZ remain challenging. Recapitalization and prudent capital management are priorities, with FY26 guidance maintained.
Comvita Quarterly report: H1 2026
Comvita has published its H1 2026 quarterly earnings report on February 22, 2026.
Comvita Slides: H1 2026
Comvita has posted slides in relation to its H1 2026 quarterly earnings report, which was published on February 22, 2026.
Comvita Transcript: AGM 2025
The meeting focused on progress in financial recovery, recapitalization, and operational reset, with significant cost reductions, debt repayment, and new leadership. Shareholders raised concerns about past governance, but the board committed to transparency, improved engagement, and strategic growth initiatives.
Comvita Slides: FY 2025
Comvita has posted slides in relation to its FY 2025 quarterly earnings report, which was published on December 16, 2025.
Comvita Earnings Call Transcript: H2 2025
FY25 saw revenue decline 4% and a net loss of $104.8 million due to impairments, with positive free cash flow achieved through inventory reduction. The business faces ongoing sector challenges, but a reset is underway, and a Scheme Implementation Agreement with Florenz offers shareholders certainty amid continued volatility.
Comvita Annual report: H2 2025
Comvita has published its H2 2025 annual report on August 28, 2025.
Comvita Slides: H2 2025
Comvita has posted slides in relation to its H2 2025 quarterly earnings report, which was published on August 28, 2025.
Comvita Annual report: H2 2025
Comvita has published its H2 2025 annual report on August 28, 2025.